Results: Berberine reduced renal injury in STZ-induced DN rat model, as evidenced by the decrease in fasting blood glucose, ratio of kidney weight to body weight, 24-h urinary protein, serum creatinine, and blood urine nitrogen
Founded in 2013 by the late visionary Brandon Truaxe, the group quickly established itself as a key market player thanks to its portfolio of innovative brands, including the highly sophisticated NIOD (Non-Invasive Options in Dermal Science), which offers high-advanced formulations for skincare and science enthusiasts, and of course, the famous The Ordinary , which has democratized pure actives at accessible prices
Key Differences at a Glance Sermorelin: - First-generation GHRH analog with decades of clinical use - Half-life: 10-20 minutes - Requires daily or twice-daily injection - FDA-approved (for GH deficiency in children, used off-label in adults) - Well-established long-term safety data - Lower cost per vial in many cases - Produces shorter, more natural GH pulses CJC-1295 (Mod GRF 1-29, without DAC): - Modified GHRH analog with improved stability - Half-life: approximately 30 minutes - Can be dosed 1-3 times daily - Not FDA-approved but widely used in clinical practice - Produces stronger GH pulses per injection - Often combined with Ipamorelin for combined effect - More potent per microgram than Sermorelin The fundamental difference is potency and duration
More clinical research should investigate the effectiveness across different patient conditions, but the existing evidence suggests the treatments are generally safe, well tolerated, and worth trying for those struggling with chronic pain or steroid side effects
